A study from the National Institutes of Health describes the immune response triggered by COVID-19 infection that damages the brain's blood vessels and may lead to short- and long-term neurological symptoms. In a study published ...
Jul 5, 2022
1
23
Scientists have identified a new treatment combination that is highly effective at suppressing the growth of head and neck tumors.
Jun 16, 2022
0
5
Elevated blood pressure can cause a condition known as perivascular fibrosis, where the outside wall of a blood vessel thickens due to connective tissue build-up. Although recent data has suggested that the thickening is ...
Apr 21, 2022
2
15
The brain is constantly firing and controlling purposeful action potentials—electronic messages used by neurons to communicate with each other and allow the brain to function. Conversely, the way spontaneous neural communication ...
Feb 15, 2022
0
7
A new batch of prognostic cancer biomarkers have been discovered in an area where few have gone looking before. Researchers have unveiled a catalog of 166 prognostic biomarkers, generated by analyzing long non-coding RNAs ...
Nov 15, 2021
0
54
Oncotarget has published a report that aerobic exercise is receiving increased recognition in oncology for its multiple purported benefits.
Nov 10, 2021
0
1
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. New research published in the Journal of Leukocyte Biology reveals that certain protein markers may indicate which patients have stable ...
Jul 21, 2021
0
3
CHARGE syndrome is a rare genetic disorder affecting about 1 in 10,000 newborns. It can lead to neurological and behavioral disorders for which no treatment is currently available. Dr. Kessen Patten and his team from the ...
Apr 28, 2021
0
0
Recent studies have shown that immune response plays a central role in the severity of COVID-19. Understanding the immune responses generated as the disease progresses is therefore key to determining which patients are at ...
Mar 5, 2021
0
4
A research team led by the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) has built the first cellular model to depict the evolution of acute myeloid leukemia (AML), from its early to late stages. By using gene ...
Feb 10, 2021
0
50
